On October 1, 2021 the CNS is proud to announce a new and improved user experience for all your SANS education needs. You’ll retain access to any current subscriptions
but answers on exams won’t transfer over - so make sure you complete any exams and claim credit by September 30 or start the new SANS 2021 today

  • Perioperative Antibiotic Use in Vagus Nerve Stimulator Implantation

    Final Number:
    637

    Authors:
    Arvind Mohan BS; Rory R. Mayer MD; Daniel Hansen MD; Daniel Curry MD; Sandi Lam MD MBA

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2016 Annual Meeting

    Introduction: Surgical antibiotic prophylaxis contributes up to 1/3 of total antibiotic use in major hospitals. With the growing problem of antimicrobial resistance worldwide, it is important to examine the current practice of antibiotic use in surgical prophylaxis. We examined our institution’s experience with vagus nerve stimulator implantation to see how perioperative antibiotic practices impacted postoperative infectious outcomes.

    Methods: We conducted a single center case control study with a retrospective chart review of 41 consecutive patients undergoing vagus nerve stimulator (VNS) implantation over 12 months. Patient demographics, perioperative details, and 6 month follow up of infections and healthcare utilization were recorded.

    Results: 41 patients underwent VNS implantation at our institution between July 2014 and June 2015. One of two surgeons operated on each patient in the same operating room with the same surgical team, differing by practice preference in choice of antibiotic prophylaxis. Patients either received a single dose of intravenous (IV) cefazolin, or a dose of IV cefazolin and one or both of gentamicin/vancomycin in addition to a 10 day outpatient oral antibiotic course of clindamycin. 24 patients received one dose of peroperative cefazolin as surgical prophylaxis, and 17 patients received =2 perioperative IV antibiotics and PO antibiotics. No patients in either group had VNS implant infection in 6 months following surgery. 8 patients who received only one antibiotic and 6 patients who received =2 antibiotics had other non-implant-related infections in 6 months following VNS placement, ranging from sinusitis to bacteremia. The differences between the two groups in infections (p=1.0) were not significant. There were also no significant differences between the two groups in terms of both inpatient admissions after surgery (p=0.66) and overall seizure control outcome (p=0.11).

    Conclusions: Multiple perioperative prophylactic antibiotics did not significantly impact rate of postoperative infection events compared to a single dose of preoperative cefazolin.

    Patient Care: Demonstrating recommended use of perioperative antibiotics encourages cost-effective care and addresses antimicrobial resistance.

    Learning Objectives: Identify recommended perioperative antibiotic practice for vagus nerve stimulator implantation. Discuss impact of perioperative antibiotic use.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy